---
schema_version: "secwatch.filing_event.v1"
accession: "0001740797-24-000019"
form_type: "8-K"
ticker: "AVAI"
cik: "0001740797"
company_name: "AVAI BIO, INC."
filed_at: "2024-05-07T23:59:59+00:00"
generated_at: "2026-06-02T19:19:56.299803+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Avant Technologies designates Series B Convertible Preferred Stock for Wired4Health asset acquisition

## Summary
- Filed Certificate of Designation for 1M shares of Series B Convertible Preferred Stock.
- Series B issued as partial consideration for acquiring Wired4Health assets; total consideration $2.2M.
- Conversion price set at lesser of $1.00 per share or 30-day VWAP of common stock on OTC Markets.
- Conversion subject to 4.99% beneficial ownership limitation and daily sales cap of 25% of total volume.
- Preferred Stock has aggregate stated value of $1M; Secured Note of $1.2M also issued.

## SEC filing metadata
- accession: 0001740797-24-000019
- form_type: 8-K
- ticker: AVAI
- cik: 0001740797
- company_name: AVAI BIO, INC.
- filed_at: 2024-05-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1740797/000174079724000019/0001740797-24-000019-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1740797/000174079724000019/avai_8kcert.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001740797-24-000019
- JSON: https://secwatch.observer/filing/0001740797-24-000019.json
- Plain text: https://secwatch.observer/filing/0001740797-24-000019.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.